Clinical trial Recruiting at 22 sites Phase 4 Interventional Ages 18 and up Women only

Comparing Metformin and Insulin for Gestational Diabetes Treatment

Official title: DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes

Run by Ohio State University · NCT06445946 · Data updated 2026-11-12

This study is testing whether metformin is as effective as insulin for treating gestational diabetes in pregnant people and looks at how safe both treatments are for mothers and their babies.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment1572 (estimated)
SponsorOhio State University
Academic / other
Locations26 sites (Tuscaloosa, Alabama and 25 other locations)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedDecember 2029
Study endsDecember 2030
Registry record updatedOctober 7, 2026
Trial IDNCT06445946 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals aged 18 and older diagnosed with gestational diabetes who require medication for glucose control.

Probably not a fit

Patients with renal disease, major fetal malformations, or contraindications to metformin or insulin will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares the effectiveness of metformin versus insulin in treating gestational diabetes mellitus (GDM) in pregnant individuals. It is a randomized controlled trial involving 1,572 participants across 20 U.S. sites, focusing on whether metformin is as effective as insulin in reducing adverse pregnancy outcomes. The study also aims to assess the safety of both treatments for mothers and their children, as well as to explore patient-reported experiences regarding the use of these medications. Participants will be followed from pregnancy through two years postpartum to gather comprehensive data.

Why it matters

Potential benefit: If successful, this study could provide evidence that metformin is a safe and effective alternative to insulin for managing gestational diabetes, potentially improving treatment options for patients.

How similar studies have gone: Previous studies have indicated that both metformin and insulin are effective for managing gestational diabetes, but this study aims to provide more definitive comparative effectiveness data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton gestation. Twin reduction to singleton, either spontaneously or therapeutically, is eligible if it occurred before 14 weeks gestational age.
* Age 18 years or older
* Gestational age at randomization between 20 0/7 - 33 6/7 weeks based on project gestational age.
* GDM diagnosis less than or equal to 33 6/7 weeks based on project gestational age.
* Requires medication for glucose control defined as ≥ 30% elevated glucose values (either fasting or postprandial or both) prior to randomization per determination of the provider or documented in the medical record.
* Patient willingness and ability to attend 2-year follow-up visit.

Exclusion criteria:

* Renal disease (serum creatinine \>1.3 mg/dL) due to the potential impact of metformin on renal function.
* Major structural malformation of the fetus.
* Known fetal aneuploidy based on invasive testing or positive for aneuploidy on cell-free fetal DNA screening.
* Contraindication to metformin or insulin, including: history of lactic acidosis, intractable nausea and vomiting, prior documented allergy and/or anaphylaxis.
* For individuals with GDM diagnosed \<20 0/7 weeks, documented A1c ≥\>6.5% within prior 6 months.
* Pregestational diabetes documented in the medical record or prior A1c\>= 6.5%
* Fasting hyperglycemia \>115 mg/dl for ≥ 50% of fasting glucose values in the past week (due to the high risk of metformin failure with fasting hyperglycemia).
* Enrolled in a trial that influences primary study outcomes (composite neonatal outcome at delivery or childhood body mass index at 2 years).
* Prenatal care or delivery planned at a location where access to the complete electronic medical record will not be available to research staff.
* Language barrier (appropriate translation resources unavailable at the site)
* Participation in this trial in a previous pregnancy. Patients who were screened in a previous pregnancy, but not randomized, may be included.

Where it's running

  • University of Alabama
    Tuscaloosa, Alabama, United States
    Recruiting
  • Cedars Sinai Medical Center
    Los Angeles, California, United States
    Recruiting
  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Yale School of Medicine
    New Haven, Connecticut, United States
    Recruiting
  • University of South Florida
    Tampa, Florida, United States
    Recruiting
  • Tufts University
    Boston, Massachusetts, United States
    Recruiting
Show 20 more locations
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Washington University in St. Louis
    St Louis, Missouri, United States
    Recruiting
  • University of New Mexico
    Albuquerque, New Mexico, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • Wake Forest University
    Winston-Salem, North Carolina, United States
    Recruiting
  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
    Columbus, Ohio, United States
    Recruiting
  • Premier Health - Miami Valley Hospital
    Dayton, Ohio, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Brown University
    Providence, Rhode Island, United States
    Recruiting
  • University of South Carolina Greenville
    Greenville, South Carolina, United States
    Recruiting
  • University of Texas Austin
    Austin, Texas, United States
    Recruiting
  • Austin Maternal Fetal Medicine
    Austin, Texas, United States
    Recruiting
  • University of Texas Health Science Center
    Houston, Texas, United States
    Recruiting
  • Eastern Virginia Medical School - Old Dominion University
    Norfolk, Virginia, United States
    Recruiting
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting
  • Christiana Care
    Newark, Delaware, United States
    Withdrawn
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Terminated
  • University of North Caroline
    Chapel Hill, North Carolina, United States
    Withdrawn
  • Kettering Health
    Kettering, Ohio, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.